PTIX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 01:36):

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders...

Stats
今日成交量	3 714.00
平均成交量	11 972.00
市值	6.52M
EPS	$0 ( 2024-04-02 )
下一个收益日期	( $0 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.280
ATR14	$0.0820 (5.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Wright Timothy R	Buy	21 250	PTIX Common stock Options
2024-03-25	Stein Robert Benjamin	Buy	75 000	PTIX Common stock Options
2024-03-25	Barrage Khalil	Buy	22 500	PTIX Common stock Options
2024-03-25	Buell Jennifer	Buy	75 000	PTIX Common stock Options
2024-03-25	Armen Garo H	Buy	250 000	PTIX Common stock Options

INSIDER POWER
100.00
Last 91 transactions
Buy: 6 726 731 \| Sell: 101 568 933

Protagenic Therapeutics, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Protagenic Therapeutics, 财务报表

Annual	2023
营收:	$0
毛利润:	$-28 218.00 (0.00 %)
EPS:	$-1.150

FY	2023
营收:	$0
毛利润:	$-28 218.00 (0.00 %)
EPS:	$-1.150

FY	2022
营收:	$0
毛利润:	$-30.00 (0.00 %)
EPS:	$-0.830

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.310

Financial Reports:

No articles found.

Protagenic Therapeutics,

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.